5 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital

Page 1 of 5

In this piece, we will take a look at the top 5 pharmaceutical stocks to buy according to Peter Kolchinsky’s RA Capital. If you want a comprehensive view of Dr. Kolchinsky’s portfolio and his investment strategy, head on over to 15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital.

5. Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX)

RA Capital Management’s Stake Value: $208.9 million

Percentage of RA Capital Management’s 13F Portfolio: 2.89%

Number of Hedge Fund Holders: 16

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) is an American company that focuses on developing treatments for liver and cancer diseases. It was founded in 2007 and is headquartered in Watertown, Massachusetts.

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) earned -$0.91 in its GAAP EPS for the third quarter, beating analyst estimates. The company’s share price target was lowered to $53 by H.C. Wainwright in an August 2021 analyst note.

Dr. Kolchinsky’s RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. During Q3 2021, 16 of the 873  hedge funds polled by Insider Monkey had holdings in the company.

Page 1 of 5